Projects per year
Fingerprint Dive into the research topics where Paul F. Riska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 13 Similar Profiles
Mycobacterium tuberculosis
Medicine & Life Sciences
Luciferases
Medicine & Life Sciences
Mycobacteriophages
Medicine & Life Sciences
Bacteriophages
Medicine & Life Sciences
Clostridium difficile
Medicine & Life Sciences
Clostridium Infections
Medicine & Life Sciences
Mycobacterium
Medicine & Life Sciences
Anti-Bacterial Agents
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 1998 2004
- 1 Finished
Mycobacterium
Tuberculosis
Bacteriophages
Molecular Biology
Mycobacteriophages
Publications 1989 2019
4
Citations
(Scopus)
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
INSIGHT FLU-IVIG Study Group, Nov 2019, In : The Lancet Respiratory Medicine. 7, 11, p. 951-963 13 p.Research output: Contribution to journal › Article
Open Access
Intravenous Immunoglobulins
Human Influenza
Randomized Controlled Trials
Placebos
Infection
10
Citations
(Scopus)
Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia a randomized clinical trial
the Staphylococcal Bacteremia Investigators, Sep 25 2018, In : JAMA - Journal of the American Medical Association. 320, 12, p. 1249-1258 10 p.Research output: Contribution to journal › Article
Bacteremia
Randomized Controlled Trials
Therapeutics
Anti-Bacterial Agents
Coagulase
1
Citation
(Scopus)
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
For the INSIGHT FLU003 Plus Study Group, Jan 1 2018, In : Open Forum Infectious Diseases. 5, 1, ofx228.Research output: Contribution to journal › Article
Indoleamine-Pyrrole 2,3,-Dioxygenase
Human Influenza
Disease Progression
Tryptophan
Kynurenine
1
Citation
(Scopus)
Two for the price of one: Emerging carbapenemases in a returning traveller to New York City
Mittal, J., Szymczak, W. A., Guo, Y., Levi, M. H., Chen, L., Kreiswirth, B. N., Riska, P. F. & Nori, P., Jan 1 2018, In : BMJ Case Reports. 2018, bcr-2018-225440.Research output: Contribution to journal › Article
Carbapenems
Bangladesh
Enterobacteriaceae Infections
Aztreonam
Klebsiella pneumoniae
42
Citations
(Scopus)
Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
CoDIFy study group, Jul 1 2017, In : The Lancet Infectious Diseases. 17, 7, p. 735-744 10 p.Research output: Contribution to journal › Article
Clostridium Infections
Clostridium difficile
Vancomycin
Safety
Therapeutics